Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2

https://doi.org/10.1016/j.neulet.2007.11.074Get rights and content

Abstract

Alcohol, nicotine, and cannabinoid acutely increase the activity of the mesolimbic dopamine (DA) pathway. Although polysubstance consumption is a common pattern of abuse in humans, little is known about dopamine release following pre-exposure to these drugs. The purpose of this study was to test whether alcohol-induced dopamine release into the nucleus accumbens (NAc) shell is modified by different pre-treatments: water (i.g.), alcohol (1 g/kg, i.g.), nicotine (0.4 mg/kg, s.c.), and WIN 55,212-2 (1 mg/kg, s.c.). Male Wistar rats were treated (i.g.) for 14 days with either water or alcohol. In the following 5 days rats were injected (s.c.) with vehicle, nicotine, or WIN 55,212-2. Finally, a cannula was surgically implanted into the NAc shell and alcohol-induced extracellular dopamine release was monitored in freely moving rats. Alcohol (1 g/kg; i.g.) only increased the release of dopamine when animals were previously treated with water. This DA increase was markedly inhibited by (subchronic) treatment (5 days) with nicotine or WIN 55-212-2 as well as by previous (chronic) exposure to alcohol (14 days). These data demonstrate that pre-treatment with nicotine and the cannabinoid agonist WIN 55,212-2 is able to change the sensitivity of the NAc shell in response to a moderate dose of alcohol. Therefore, cannabinoid and nicotine exposure may have important implications on the rewarding effects of alcohol, because these drugs lead to long-lasting changes in accumbal dopamine transmission.

Section snippets

Acknowledgements

This work was supported by The European Fith Framework Programme QLRT-2000-01691, Ministerio de Ciencia y Tecnología Grant BFI-2001-C02-01, Fondo de Investigación Sanitaria (Red Trastornos Adictivos), M.S.C (Plan Nacional Sobre Drogas), M.E.C.

References (41)

  • R.Y. Shen et al.

    Long-term reduction in ventral tegmental area dopamine neuron population activity following repeated stimulant or ethanol treatment

    Biol. Psychiatry

    (2007)
  • B. Soderpalm et al.

    Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol

    Behav. Brain Res.

    (2000)
  • E. Tupala et al.

    Measurement of the striatal dopamine transporter density and heterogeneity intype 1 alcoholics using human whole hemisphere autoradiography

    Neuroimage

    (2001)
  • M.A. Ungless

    Dopamine: the salient issue

    Trends Neurosci.

    (2004)
  • M. Van der Stelt et al.

    The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders

    Eur. J. Pharmacol.

    (2003)
  • S. Vlachou et al.

    WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation

    Behav. Brain Res.

    (2003)
  • L.N. Voruganti et al.

    Cannabis induced dopamine release: an in vivo SPECT study

    Psychiatry Res.

    (2001)
  • H.J. Aubin et al.

    Changes in cigarette smoking and coffee drinking after alcohol detoxification in alcoholics

    Addiction

    (1999)
  • I. Boileau et al.

    Alcohol promotes dopamine release in the human nucleus accumbens

    Synapse

    (2003)
  • J.F. Cheer et al.

    Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats

    J. Neurosci.

    (2004)
  • Cited by (19)

    • The incentive amplifying effects of nicotine: Roles in alcohol seeking and consumption

      2022, Advances in Pharmacology
      Citation Excerpt :

      As discussed previously, nicotine appears to better enhance voluntary alcohol intake when it is given in exposure windows either developmentally or temporally dissociated from the period of alcohol consumption. In contrast to the previously described studies, subchronic nicotine can actually blunt alcohol-induced DA release in the NAccSh (Lopez-Moreno et al., 2008). The effect of nicotine pre-exposure can persist long after it is metabolized, attenuating the alcohol-induced release of NAcc DA and VTA firing, while producing concurrent increases in alcohol consumption (Doyon, Dong, et al., 2013).

    • Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse

      2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry
      Citation Excerpt :

      That is, simultaneous co-administration of nicotine and alcohol produces an additive increase in NAc dopamine release relative to the response of each drug (Tizabi et al., 2002; Doyon et al., 2013a, 2013b). Perhaps surprisingly, pretreatment with nicotine diminishes the sensitivity of the mesolimbic dopamine system to alcohol (Lopez-Moreno et al., 2008; Doyon et al., 2013a, 2013b; Ostroumov et al., 2015). An acute 3, 15 or 40 h pretreatment with nicotine (0.4 mg/kg, ip) significantly blunted the alcohol (1.5 g/kg, iv)-induced increase in dopamine release in rat NAc (Doyon et al., 2013a, 2013b).

    • Cigarettes and alcohol: The influence of nicotine on operant alcohol self-administration and the mesolimbic dopamine system

      2015, Biochemical Pharmacology
      Citation Excerpt :

      The nicotine and ethanol interaction has been shown to activate a set of interconnected brain structures involved in stress and reward processing, including the ventral tegmental area (VTA), nucleus accumbens, dorsomedial prefrontal cortex, and extended amygdala [63]. Pretreatment with nicotine has been shown to decrease the responsiveness of the DA system to ethanol [22,79]. We have shown that pretreatment with nicotine (3–40 h prior to testing) decreases the amplitude and the time course of ethanol-induced DA signals in the VTA and the nucleus accumbens when compared to control animals pretreated with saline [22].

    • Potential substrates for nicotine and alcohol interactions: A focus on the mesocorticolimbic dopamine system

      2013, Biochemical Pharmacology
      Citation Excerpt :

      Local blockade of CB1 receptors in the VTA and the NAc reduces alcohol consumption, suggesting a critical role of eCB signaling in the mesoaccumbens pathway [233]. Pretreatment with a CB1 receptor agonist or with nicotine blocked alcohol-induced DA release, suggesting that these agents may interact with alcohol through a common mechanism [105]. In addition, alcohol increases conditioned place preference induced by nicotine, and this effect is prevented by blocking eCB receptors [234].

    View all citing articles on Scopus
    1

    Both authors have participated equally to this work.

    View full text